Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Equity (2016 - 2025)

Historic Return on Equity for Ani Pharmaceuticals (ANIP) over the last 15 years, with Q3 2025 value amounting to 0.09%.

  • Ani Pharmaceuticals' Return on Equity rose 1000.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.04% for FY2024, which is 800.0% down from last year.
  • Ani Pharmaceuticals' Return on Equity amounted to 0.09% in Q3 2025, which was up 1000.0% from 0.02% recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Return on Equity registered a high of 0.09% during Q3 2025, and its lowest value of 0.17% during Q2 2022.
  • Over the past 5 years, Ani Pharmaceuticals' median Return on Equity value was 0.05% (recorded in 2025), while the average stood at 0.05%.
  • In the last 5 years, Ani Pharmaceuticals' Return on Equity surged by 2000bps in 2023 and then crashed by -1200bps in 2025.
  • Ani Pharmaceuticals' Return on Equity (Quarter) stood at 0.15% in 2021, then rose by 19bps to 0.12% in 2022, then skyrocketed by 133bps to 0.04% in 2023, then tumbled by -202bps to 0.04% in 2024, then surged by 312bps to 0.09% in 2025.
  • Its Return on Equity stands at 0.09% for Q3 2025, versus 0.02% for Q2 2025 and 0.05% for Q1 2025.